SCHEMBL2713930

SCHEMBL2713930

NC(=O)c1cnc(Cl)cc1N(c1ccccc1)C1CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 3/20 0.39
▸ OPRD1 P41143 3/20 0.39
▸ CYP3A4 P08684 2/20 0.37
▸ CASP1 P29466 1/20 0.35
▸ SYK P43405 1/20 0.35
▸ OPRK1 P41145 2/20 0.35
▸ JAK3 P52333 2/20 0.34
▸ JAK2 O60674 2/20 0.34
▸ JAK1 P23458 2/20 0.34
▸ TYK2 P29597 1/20 0.34
▸ IRAK4 Q9NWZ3 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ MAPK8 P45983 1/20 0.34
▸ MAPK9 P45984 1/20 0.34
▸ KCNH2 Q12809 2/20 0.34
▸ CHEK1 O14757 1/20 0.34
▸ CCR5 P51681 2/20 0.33
▸ NNMT P40261 1/20 0.33
▸ PARP1 P09874 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2713874 0.75 ALDH1A1 (0.40) CASP1JAK3JAK2JAK1TYK2
SCHEMBL3718972 0.73 CYP3A4 (0.43) CYP3A4SYKCCR5TGFBR1
SCHEMBL2713612 0.71 MAPK10 (0.55) SYKMAPK8MAPK9
SCHEMBL3722179 0.71 SMN1; SMN2 (0.42) SYKALDH1A1
SCHEMBL2497244 0.70 RPS6KB1 (0.49) JAK3JAK2JAK1TYK2IRAK4
SCHEMBL913751 0.69 MKNK1 (0.44) SYK
SCHEMBL3713598 0.69 MEN1 (0.36) OPRM1OPRD1CYP3A4SYKJAK3
SCHEMBL19971151 0.69 CYP3A4 (0.35) CYP3A4KCNH2CCR5
SCHEMBL2480282 0.67 JAK3 (0.67) JAK3JAK2JAK1TYK2IRAK4
SCHEMBL21596400 0.66 JAK3 (0.55) SYKJAK3JAK2JAK1TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2635557-A2 NICOTINAMIDES AS JAK KINASE MODULATORS Portola Pharmaceuticals, Inc. (US) 2013-09-11 — — EP disclosed
WO-2012061428-A2 NICOTINAMIDES AS JAK KINASE MODULATORS PORTOLA PHARMACEUTICALS, INC. (US) 2012-05-10 — — WO disclosed
Send feedback